Intrexon | XON - Market Capitalization


Intrexon reported $1.06B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 21.73B 3B May/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
MacroGenics USD 102M 4M Dec/2025
MannKind USD 965M 208M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.59B 16M May/2026
Xencor USD 795M 98M May/2026